chr5-172333700-AGAGT-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001017995.3(SH3PXD2B):c.*4665_*4668del variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000954 in 1,289,418 control chromosomes in the GnomAD database, including 23 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00059 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 21 hom. )
Consequence
SH3PXD2B
NM_001017995.3 3_prime_UTR
NM_001017995.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.830
Genes affected
SH3PXD2B (HGNC:29242): (SH3 and PX domains 2B) This gene encodes an adapter protein that is characterized by a PX domain and four Src homology 3 domains. The encoded protein is required for podosome formation and is involved in cell adhesion and migration of numerous cell types. Mutations in this gene are the cause of Frank-ter Haar syndrome (FTHS), and also Borrone Dermato-Cardio-Skeletal (BDCS) syndrome. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000591 (90/152290) while in subpopulation SAS AF= 0.0172 (83/4824). AF 95% confidence interval is 0.0142. There are 2 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3PXD2B | NM_001017995.3 | c.*4665_*4668del | 3_prime_UTR_variant | 13/13 | ENST00000311601.6 | NP_001017995.1 | ||
SH3PXD2B | XM_017009351.2 | c.*4665_*4668del | 3_prime_UTR_variant | 14/14 | XP_016864840.1 | |||
SH3PXD2B | NM_001308175.2 | c.1189-8324_1189-8321del | intron_variant | NP_001295104.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3PXD2B | ENST00000311601.6 | c.*4665_*4668del | 3_prime_UTR_variant | 13/13 | 1 | NM_001017995.3 | ENSP00000309714 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152172Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
91
AN:
152172
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00231 AC: 310AN: 134130Hom.: 8 AF XY: 0.00310 AC XY: 227AN XY: 73146
GnomAD3 exomes
AF:
AC:
310
AN:
134130
Hom.:
AF XY:
AC XY:
227
AN XY:
73146
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00100 AC: 1140AN: 1137128Hom.: 21 AF XY: 0.00147 AC XY: 821AN XY: 557816
GnomAD4 exome
AF:
AC:
1140
AN:
1137128
Hom.:
AF XY:
AC XY:
821
AN XY:
557816
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000591 AC: 90AN: 152290Hom.: 2 Cov.: 32 AF XY: 0.000886 AC XY: 66AN XY: 74482
GnomAD4 genome
AF:
AC:
90
AN:
152290
Hom.:
Cov.:
32
AF XY:
AC XY:
66
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Frank-Ter Haar syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at